Skip to main content
Clinical Trials/NCT01141764
NCT01141764
Terminated
Phase 3

Cerebral Metabolic Changes Associated With Thalamic Stimulation

The Hospital for Sick Children2 sites in 1 country4 target enrollmentMarch 2010
ConditionsEpilepsy

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Epilepsy
Sponsor
The Hospital for Sick Children
Enrollment
4
Locations
2
Primary Endpoint
Areas of the brain with low activity
Status
Terminated
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this research study is to evaluate the brain circuits function and circuits involved in the mechanism of thalamic DBS in patients with medically refractory epilepsy.

Detailed Description

Deep brain stimulation (DBS) of the anterior nucleus of the thalamus in patients with medically refractory epilepsy has been shown to be efficacious. Studies have estimated a 46-76% reduction in seizures relative to the baseline. However, the exact anatomic circuitry involved in the mechanism of DBS in epilepsy remains unknown. Positron emission tomography (PET) studies can provide clues to the metabolic activity associated with DBS activation. In our study, patients will be scanned with their DBS electrodes turned "on" and "off". PET data captured during these two distinct states may show characteristic differences in cerebral glucose metabolism and modulatory effects of surrounding cerebral structures, thus providing clues to how DBS works to prevent seizures.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
February 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Elysa Widjaja

Staff Neuroradiologist

The Hospital for Sick Children

Eligibility Criteria

Inclusion Criteria

  • 18-85 years old
  • currently have DBS implanted for medically refractory epilepsy
  • Women of childbearing age will be required to use established contraceptive methods while enrolled in the study.

Exclusion Criteria

  • Patients who:
  • are \< 18 years of age or \> 85 years of age
  • are medically unstable
  • are women who are potentially pregnant, pregnant or nursing
  • have had PET imaging within 1 year.

Outcomes

Primary Outcomes

Areas of the brain with low activity

Time Frame: within 30 days of enrollment in the study

This measure will be based on the results of two PET scans done on separate days. The stimulator will be "on" during the first PET image acquisition and "off" during the second PET image acquisition.

Secondary Outcomes

  • Brain Abnormalities(within 30 days of enrollment in the study)
  • Ability to learn and understand(within 30 days of enrollment in the study)

Study Sites (2)

Loading locations...

Similar Trials